M&A Deal Summary |
|
|---|---|
| Date | 2022-01-18 |
| Target | GeneDx |
| Sector | Life Science |
| Buyer(s) | Sema4 |
| Sellers(s) | Bio-Reference Laboratories |
| Deal Type | Divestiture |
| Deal Value | 623M USD |
| Advisor(s) | Fenwick & West (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Sema4 is an AI- and machine learning-driven patient-centered genomic and clinical data intelligence company that uses Centrellis unique advanced analytics platform, to build predictive models of human health to deliver personalized insights for patients in the areas of women’s health and precision oncology, as well as more generalized genomic health screening and modeling across the spectrum of disease. Sema4 is based in Stamford, Connecticut.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector (Life Science) | 1 of 1 |
| Type (Divestiture) | 1 of 1 |
| State (Maryland) | 1 of 1 |
| Country (United States) | 1 of 1 |
| Year (2022) | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 1981 |
| Sector | Life Science |
| Employees | 3,406 |
| Revenue | 832M USD (2014) |
Bio-Reference Laboratories, Inc. is a full service clinical diagnostic laboratory in the U.S. providing testing and related services to physician offices, clinics, hospitals, long term care facilities, employers, governmental units and correctional institutions.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector (Life Science) | 2 of 2 |
| Type (Divestiture) | 2 of 2 |
| State (Maryland) | 2 of 2 |
| Country (United States) | 2 of 2 |
| Year (2022) | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-08-16 |
Roche Holding - U.S. Ariosa Centralized Laboratory Prenatal Testing Business
Elmwood Park, New Jersey, United States Roche Holding's U.S. Ariosa Centralized Laboratory Prenatal Testing Business is a noninvasive prenatal screening (NIPS) test, the Harmony Prenatal Test, which is one of the most widely studied tests utilized in prenatal screening. The test has been performed in over 1.5 million patients. Roche Holding's U.S. Ariosa Centralized Laboratory Prenatal Testing Business is based in Elmwood Park, New Jersey. |
Buy | - |
